Depression is an early disease manifestation in lupus-prone MRL/lpr mice

被引:66
|
作者
Gao, Hua-Xin [2 ]
Campbell, Sean R. [2 ]
Cui, Min-Hui [3 ]
Zong, Pu [3 ]
Hee-Hwang, Jong [3 ]
Gulinello, Maria [4 ]
Putterman, Chaim [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Magnet Resonance Res Ctr, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA
关键词
Systemic Lupus Erythematosus; Neuropsychiatric lupus; Anti-DNA antibodies; Depression; MRL-LPR MICE; MAGNETIC-RESONANCE-SPECTROSCOPY; RIBOSOMAL-P ANTIBODIES; AUTOREACTIVE B-CELLS; ELEVATED-PLUS-MAZE; PSYCHIATRIC MANIFESTATIONS; NEUROPSYCHIATRIC MANIFESTATIONS; ANTIPHOSPHOLIPID SYNDROME; PROTEIN AUTOANTIBODIES; COGNITIVE IMPAIRMENT;
D O I
10.1016/j.jneuroim.2008.11.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many lupus patients develop neuropsychiatric manifestations, including cognitive dysfunction, depression, and anxiety. However, it is not clear if neuropsychiatric lupus is a primary disease manifestation, or is secondary to non-CNS disease. We found that MRL/lpr lupus-prone mice exhibited significant depression-like behavior already at 8 weeks of age, despite normal visual working memory, locomotor coordination and social preference. Moreover, depression was significantly correlated with titers of autoantibodies against DNA, NMDA receptors and cardiolipin. Our results indicate that lupus mice develop depression and CNS dysfunction very early in the course of disease, in the absence of substantial pathology involving other target organs. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [1] Depression is an Early Disease Manifestation in Lupus Prone MRL/lpr Mice
    Gao, Huo-Xin
    Campbell, Sean
    Cui, Min-Hui
    Zong, Pu
    Hwang, Jong-Hee
    Gulinello, Maria
    Putterman, Chaim
    [J]. CLINICAL IMMUNOLOGY, 2009, 131 : S46 - S46
  • [2] Receptor editing is impaired in lupus-prone MRL/lpr mice
    Feeney, Ann J.
    Lamoureux, Jennifer
    Nemazee, David
    Watson, Lisa
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 : S152 - S152
  • [3] Therapeutic Effects of Triptolide on Lupus-prone MRL/lpr Mice
    Huang, Xueqin
    Wen, Chengping
    Wei, Hua
    [J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (05) : 681 - 688
  • [4] Fate of immune deposits in lupus-prone MRL/Mp lpr/lpr mice
    Cruse, JM
    Lewis, RE
    Dilioglou, S
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1208 - A1208
  • [5] Mitochondrial Dysfunction in the Liver of Lupus-Prone MRL/Lpr Mice Prior to Disease Onset
    Oaks, Zachary A.
    Telarico, Tiffany
    Perl, Andras
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S624 - S625
  • [6] hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
    Fengbiao Guo
    Quanren Pan
    Ting Chen
    Shuzhen Liao
    Shangmei Li
    Aifen Li
    Shuxian Chen
    Jiaxuan Chen
    Zengzhi Xiao
    Hongyong Su
    Lawei Yang
    Chen Yang
    Hua-feng Liu
    Qingjun Pan
    [J]. Stem Cell Research & Therapy, 14
  • [7] hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
    Guo, Fengbiao
    Pan, Quanren
    Chen, Ting
    Liao, Shuzhen
    Li, Shangmei
    Li, Aifen
    Chen, Shuxian
    Chen, Jiaxuan
    Xiao, Zengzhi
    Su, Hongyong
    Yang, Lawei
    Yang, Chen
    Liu, Hua-feng
    Pan, Qingjun
    [J]. STEM CELL RESEARCH & THERAPY, 2023, 14 (01)
  • [8] Treatment of Lupus-prone MRL-lpr Mice with the Mitochondrial Antioxidant MitoQ
    Budd, Ralph
    Fortner, Karen
    Blanco, Luz
    Kaplan, Mariana
    Perl, Andras
    Busliewicz, Iwona
    MacPherson, Greg
    Murphy, Mike
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice
    Hirata, D
    Iwamoto, M
    Yoshio, T
    Okazaki, H
    Masuyama, J
    Mimori, A
    Minota, S
    [J]. CLINICAL IMMUNOLOGY, 2000, 97 (01) : 50 - 58
  • [10] Therapeutic effect of dihydroartemisinin on lupus-prone MRL/lpr mice and its mechanism of action
    Jiang, A'pei
    Pan, Jieli
    Jiang, Fusheng
    Li, Meiya
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 9839 - 9844